|Articles|May 4, 2012

Paul Dobesh, PharmD, Points Out the Benefits of Combining Anticoagulant and Antiplatelet Treatments

Dr. Dobesh addresses the challenges of achieving efficacy without having the patient bleed when combining anticoagulant and antiplatelet treatments.

Paul Dobesh, PharmD, addresses the challenges in trying to simplify medication regiments in cardiovascular disease to improve clinical outcomes and increase adherence.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Trending on AJMC

Paul Dobesh, PharmD, Points Out the Benefits of Combining Anticoagulant and Antiplatelet Treatments

Related Content

Closed-Loop Referrals Are Key to Social Care Success: Halima Ahmadi-Montecalvo, PhD, MPH

Adapting Breast Cancer Therapy to the Individual, Not Just the Scan: Lidia Schapira, MD

Iberdomide Approval Elevates MRD’s Role in Myeloma: Prerna Mewawalla, MD

Communication Is Key to Successful Cell Therapy Trials: Bridget Keenan, MD, PhD

CAR T, Bispecifics Reshape Relapsed Lymphoma Care: Madhav Seshadri, MD

Trending on AJMC

5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug

Iberdomide Approval Elevates MRD’s Role in Myeloma: Prerna Mewawalla, MD

Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care

ICER Draft Flags High Cost of New Hypertension Drug Class

AI Model Outperforms Apnea-Hypopnea Index in Predicting Sleep Apnea Mortality Risk